Drooid Logo
Back to story perspectives

Full Breakdown

Allegations Against San Diego ER Doctor Prompt Drug Testing and Supervision

4/16/2026, 8:06:50 AM

Overview of the Allegations

Dr. Ariana Dillman, an emergency room physician in San Diego, is facing serious allegations of arriving at work under the influence of drugs and alcohol. According to a Medical Board of California accusation, she exhibited signs of impairment, including slurred speech, droopy eyelids, and erratic behavior while treating patients. The incident in question occurred during a June shift, leading to a formal complaint and subsequent actions by the medical board.

Actions Taken by Medical Authorities

In response to the allegations, Dr. Dillman has been mandated to undergo random drug and alcohol testing and attend a support group for her reported alcohol use disorder. Although she remains eligible to treat patients, this is contingent upon her working under close supervision. The board's accusations suggest that she has used controlled substances and dangerous drugs prior to her shifts, raising concerns about her ability to practice medicine safely.

Employer's Response

Following the incident, Dr. Dillman's employer suspended her medical privileges. This suspension reflects the seriousness of the allegations and the potential risk to patient safety. Despite these developments, Dr. Dillman has continued to work, albeit in a different capacity, as her name is now listed among the staff at Karma Massage & Spa, a facility known for cosmetic treatments.

Broader Implications

Michele Monserratt-Ramos, a patient advocate with Consumer Watchdog, highlighted that cases like Dr. Dillman's are becoming increasingly common across California. This trend raises concerns about the oversight of medical professionals and the measures in place to ensure patient safety in emergency care settings.

Criticism & Opposition

The situation has drawn criticism from various quarters, particularly regarding the decision to allow Dr. Dillman to continue treating patients under supervision. Critics argue that this could pose a risk to patient safety, emphasizing the need for stricter regulations and monitoring of healthcare professionals with substance abuse issues.

Official Statements & Responses

The Medical Board of California has not publicly commented on the specifics of Dr. Dillman's case beyond the formal accusations. However, the board's actions indicate a commitment to addressing substance abuse among medical professionals to protect public health.

Conflicting Reports & Gaps

While the Medical Board's accusations are clear, there are gaps in the public information regarding the specifics of Dr. Dillman's treatment and the extent of her alleged substance use. Additionally, the lack of detailed responses from her employer raises questions about the internal policies governing such incidents.

Verbatim Quotes

“Unfortunately, we’re seeing a lot of cases like this across the state,” — Michele Monserratt-Ramos, Patient Advocate, Consumer Watchdog.